|
US4472193A
(en)
*
|
1982-07-06 |
1984-09-18 |
The Dow Chemical Company |
Naphthyridinyloxy(or thio)phenoxy propanoic acids, derivatives thereof and methods of herbicidal use
|
|
ES2200617B1
(es)
*
|
2001-01-19 |
2005-05-01 |
Almirall Prodesfarma, S.A. |
Derivados de urea como antagonistas de integrinas alfa 4.
|
|
BRPI0718161A2
(pt)
*
|
2006-10-27 |
2013-11-26 |
Merck & Co Inc |
Composto, composição farmacêutica, e, uso do composto.
|
|
WO2008144268A1
(en)
*
|
2007-05-15 |
2008-11-27 |
Boehringer Ingelheim International Gmbh |
Urotensin ii receptor antagonists
|
|
UY31984A
(es)
*
|
2008-07-16 |
2010-02-26 |
Boehringer Ingelheim Int |
DERIVADOS DE 1-(3,4-difluorobencil)-6-oxo-1,6-dihidropirimidin-5-carboxamidas N-sustituidas y de 2-(3,4-difluorobencil)-3-oxo-2,3-dihidro-1H-pirazol-4-carboxamidas N-sustituidas.
|
|
TW201026667A
(en)
*
|
2008-09-30 |
2010-07-16 |
Merz Pharma Gmbh & Co Kgaa |
Glycine b antagonists
|
|
EP2417133A1
(en)
*
|
2009-04-06 |
2012-02-15 |
PTC Therapeutics, Inc. |
Compounds and methods for antiviral treatment
|
|
AU2011253058A1
(en)
*
|
2010-05-13 |
2012-12-06 |
Amgen Inc. |
Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
|
|
WO2013033310A1
(en)
*
|
2011-08-31 |
2013-03-07 |
Theodore Mark Kamenecka |
Modulators of rev-erb
|
|
US9586963B2
(en)
*
|
2011-09-27 |
2017-03-07 |
Genfit |
Derivatives of 6-substituted triazolopyridazines as Rev-Erb agonists
|
|
US9266876B2
(en)
*
|
2012-02-02 |
2016-02-23 |
Actelion Pharmaceuticals Ltd. |
4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives
|
|
TW201348231A
(zh)
*
|
2012-02-29 |
2013-12-01 |
Amgen Inc |
雜雙環化合物
|
|
ES2618004T3
(es)
*
|
2012-08-07 |
2017-06-20 |
Merck Patent Gmbh |
Derivados de piridopirimidina como inhibidores de proteínas quinasas
|
|
JP2016505000A
(ja)
*
|
2012-12-21 |
2016-02-18 |
エピザイム，インコーポレイティド |
Ｐｒｍｔ５阻害剤およびその使用
|
|
WO2015103527A1
(en)
*
|
2014-01-06 |
2015-07-09 |
The Scripps Research Institute |
Modulators of rev-erb
|
|
ES2735087T3
(es)
*
|
2014-12-24 |
2019-12-16 |
Gilead Sciences Inc |
Compuestos de pirimidina fusionados para el tratamiento de VIH
|
|
US11066396B2
(en)
*
|
2016-06-23 |
2021-07-20 |
Merck Sharp & Dohme Corp. |
3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors
|
|
CN109776335B
(zh)
*
|
2017-11-15 |
2022-03-18 |
武汉尚赛光电科技有限公司 |
芘的胺类衍生物及其制备方法、应用和器件
|
|
GB201810486D0
(en)
*
|
2018-06-26 |
2018-08-08 |
Imperial Innovations Ltd |
Natural killer cells
|